By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Azathioprine

Azathioprine

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|643 words

Azathioprine Drug Profile

What is Azathioprine?

Azathioprine is an immunosuppressive medication that belongs to a class of drugs called antimetabolites. It works by suppressing the immune system and is primarily used to prevent organ transplant rejection and treat certain autoimmune diseases. This medication has been a cornerstone of immunosuppressive therapy for decades and requires careful monitoring due to its potent effects on the immune system.

Uses

Azathioprine is prescribed for several medical conditions:

  • Organ transplant rejection prevention: Used in combination with other immunosuppressants to prevent the body from rejecting transplanted kidneys, liver, or heart
  • Rheumatoid arthritis: Prescribed when other treatments have failed to control joint inflammation and damage
  • Inflammatory bowel disease: Helps maintain remission in Crohn’s disease and ulcerative colitis
  • Autoimmune hepatitis: Used to reduce liver inflammation and prevent progression of the disease
  • Other autoimmune conditions: Sometimes prescribed for conditions like myasthenia gravis, systemic lupus erythematosus, and certain skin disorders

How it works

Azathioprine works by interfering with DNA and RNA synthesis in rapidly dividing cells, particularly immune cells called lymphocytes. The drug is converted in the body to compounds that block the production of purines, which are essential building blocks for genetic material. By disrupting this process, azathioprine reduces the activity of T and B cells, effectively dampening the immune response that can cause transplant rejection or autoimmune disease symptoms.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Nausea and vomiting
  • Loss of appetite
  • Fatigue and weakness
  • Hair loss
  • Increased susceptibility to infections
  • Muscle aches
  • Diarrhea
  • Skin rash

Serious side effects to watch for:

  • Signs of bone marrow suppression (unusual bruising, bleeding, or persistent infections)
  • Liver toxicity (yellowing of skin or eyes, dark urine, severe abdominal pain)
  • Increased risk of certain cancers, particularly skin cancer and lymphoma
  • Severe allergic reactions
  • Pancreatitis (severe abdominal pain, nausea, vomiting)

Warnings and precautions

  • Pregnancy category D: May cause harm to developing babies and should only be used if the potential benefits outweigh the risks
  • Regular monitoring required: Blood tests must be performed regularly to check for bone marrow suppression and liver function
  • Infection risk: Patients should avoid live vaccines and contact with people who have infections, as the medication suppresses immune function
  • Cancer screening: Regular skin examinations are recommended due to increased skin cancer risk, especially with sun exposure
  • Genetic testing consideration: Some patients with certain genetic variations may require dosage adjustments or alternative treatments

Interactions

  • Allopurinol: Significantly increases azathioprine levels, requiring dose reduction to prevent toxicity
  • ACE inhibitors: May increase risk of severe blood disorders when combined with azathioprine
  • Warfarin: Azathioprine may reduce the effectiveness of warfarin, requiring closer monitoring of blood clotting
  • Live vaccines: Should be avoided as azathioprine may prevent proper immune response and increase infection risk
  • Trimethoprim-sulfamethoxazole: May increase risk of blood disorders
  • Ribavirin: Combination may increase risk of severe anemia
  • Methotrexate: Combined use may increase risk of liver toxicity
  • Aminosalicylates: May inhibit an enzyme that processes azathioprine, potentially increasing toxicity

Check interactions with the GMJ Interaction Checker

Dosage

Azathioprine dosing varies significantly based on the condition being treated and individual patient factors. For transplant recipients, initial doses typically range from 3-5 mg per kilogram of body weight daily, often reduced to 1-3 mg/kg daily for maintenance. For autoimmune conditions like rheumatoid arthritis, doses usually start at 1 mg/kg daily and may be increased gradually to 2.5 mg/kg daily based on response and tolerance. The medication is usually taken once or twice daily with food to reduce stomach upset. Dosage adjustments are frequently necessary based on blood test results and response to treatment. All dosing decisions should be made by a qualified healthcare provider who will consider individual patient factors, kidney and liver function, and concurrent medications.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Azathioprine." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/azathioprine/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

In the news
Direct Oral Anticoagulants Show Promise Over Heparin in Cancer Blood Clots, New Analysis Finds
In the news
  • Direct Oral Anticoagulants Show Promise Over Heparin in Cancer Blood Clots, New Analysis Finds · Jul 11, 2026
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Hospital Videos Improve New Fathers’ Infant Safety Knowledge, Pilot Study Shows

A pilot study published in Pediatrics Open Science demonstrates that brief educational…

Fermentation and Sustainable Gastronomy: How Chefs are Reshaping Food’s Future

Chef Jaume Biarnés demonstrates that sustainable food systems can deliver both environmental…

FDA Approves Bemotrizinol: First New Sunscreen Ingredient in 25 Years

The FDA has approved bemotrizinol, the first new sunscreen active ingredient in…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Vitamin B9 (Folate)

By
Prof. Giorgi Pkhakadze
02/06/2026

Pioglitazone

By
Prof. Giorgi Pkhakadze
02/06/2026

Ondansetron

By
Prof. Giorgi Pkhakadze
02/06/2026

Amphotericin B

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up